This respiratory panel distinguishes between SARS-CoV-2 and influenza A and B extracted from nasopharyngeal swabs. Use of this test is ideal for identifying the cause of symptoms during influenza season. The OPTI SARS-COV-2/Influenza A/B RT-PCR Test delivers highly accurate results with high sensitivity (LoD ≤3 copies/μl). Results are available as fast as 2 hours, including RNA extraction. The test detects new SARS-CoV-2 variants of concern (UK B.1.1.7, Brazil P.1, South Africa B.1.351 and Delta B.1.617.2) based on the sequences submitted to the GISAID database.